selected publications
-
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.
Cancer.
2020
Academic Article
GET IT
Times cited: 24 -
Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
The Journal of clinical endocrinology and metabolism.
2020
Academic Article
GET IT
Times cited: 22 -
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.
Clinical lymphoma, myeloma & leukemia.
2018
Academic Article
GET IT
Times cited: 38 -
Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
Postgraduate medicine.
2016
Information Resource
GET IT
Times cited: 27 -
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score.
Journal of bone oncology.
2016
Academic Article
GET IT
Times cited: 26 - Diabetes Management in Cancer Patients. Oncology (Williston Park, N.Y.). 2016 Academic Article GET IT
-
Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
2015
Academic Article
GET IT
Times cited: 22 -
Denosumab and fracture risk in women with breast cancer.
Lancet (London, England).
2015
Article
GET IT
Times cited: 1 -
Atypical femur fractures associated with use of bisphosphonates and denosumab.
Annals of oncology : official journal of the European Society for Medical Oncology.
2015
Article
GET IT
Times cited: 7 -
Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies.
Endocrine-related cancer.
2014
Information Resource
GET IT
Times cited: 34 -
Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies.
Endocrine.
2013
Academic Article
GET IT
Times cited: 13 -
Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors.
Leukemia research.
2013
Academic Article
GET IT
Times cited: 22 -
Skeletal-related events due to bone metastases from differentiated thyroid cancer.
The Journal of clinical endocrinology and metabolism.
2012
Academic Article
GET IT
Times cited: 65 -
Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.
Oral diseases.
2012
Academic Article
GET IT
Times cited: 51 -
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
2012
Academic Article
GET IT
Times cited: 12 -
Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
The Journal of bone and joint surgery. American volume.
2011
Academic Article
GET IT
Times cited: 70 -
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
The oncologist.
2008
Academic Article
GET IT
Times cited: 103 -
Anabolic therapies for osteoporosis.
The New England journal of medicine.
2007
Article
GET IT
Times cited: 6 -
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
Diabetes care.
2006
Article
GET IT
Times cited: 3 -
Transient subclinical hyperparathyroidism in a patient with hashimoto's thyroiditis.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2006
Conference Paper
GET IT
Times cited: 3 -
Idiopathic renal hypercalciuria as an etiology for persistent post-operative parathyroid hormone elevation.
Surgery.
2005
Article
GET IT
Times cited: 2